PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PTC Therapeutics Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Operating Expenses
-$1B
CAGR 3-Years
-9%
CAGR 5-Years
-17%
CAGR 10-Years
-27%
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$20.6B
CAGR 3-Years
-3%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.3B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.7B
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.5B
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
-18%

See Also

What is PTC Therapeutics Inc's Operating Expenses?
Operating Expenses
-1B USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Operating Expenses amounts to -1B USD.

What is PTC Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-27%

Over the last year, the Operating Expenses growth was 8%. The average annual Operating Expenses growth rates for PTC Therapeutics Inc have been -9% over the past three years , -17% over the past five years , and -27% over the past ten years .

Back to Top